Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / Saudi Arabia

Peptide legality · Saudi Arabia · updated 2026-09-22

Are peptides legal in Saudi Arabia?

Restricted

Peptides are legal in Saudi Arabia only as Saudi Food and Drug Authority (SFDA)-approved prescription medicines (such as semaglutide for diabetes/obesity), while unapproved 'research' peptides like BPC-157 and TB-500 are not authorized for human use and cannot be lawfully sold, and any personal importation of peptide medicines now requires a valid prescription.

Legal status overview

Peptides are restricted in Saudi Arabia: they are lawful only when they are SFDA-approved medicines dispensed on prescription, and unapproved research peptides have no legal route to human sale. The Saudi Food and Drug Authority (SFDA) is the national regulator that approves and schedules medicines, and prescription peptide drugs like semaglutide are marketed through licensed channels. Since late 2024, Saudi Arabia has also tightened personal-import rules so that travelers and residents bringing medication generally need a valid prescription.

Key points

  • The Saudi Food and Drug Authority (SFDA) is the national regulator responsible for approving, registering, and controlling medicines and drug products in Saudi Arabia, and peptide drugs fall under its authority. [1]
  • Peptide-based weight-loss and diabetes medicines such as semaglutide are legal in Saudi Arabia as SFDA-approved, prescription products, including SFDA clearance of an oral weight-loss drug for adults with obesity. [6]
  • Generic semaglutide has been launched in Saudi Arabia through a licensed manufacturer, confirming that approved GLP-1 peptides reach patients only through the regulated prescription supply chain rather than open sale. [5]
  • Research peptides such as BPC-157 are unapproved drugs not authorized as medicines, meaning they have no lawful route to human sale in a market like Saudi Arabia that requires SFDA registration before marketing. [7]
  • Personal importation of medication into Saudi Arabia is governed by prescription-based rules introduced in late 2024, so travelers and residents generally must carry a valid prescription for medicines they bring into the country. [2]
  • Importing medicines that are not registered/approved in Saudi Arabia requires going through an SFDA authorization process rather than free purchase, which effectively blocks casual import of unapproved research peptides. [4]
  • No Saudi statute specifically naming 'peptides' as a category was located; peptides are instead governed by the general SFDA drug-registration, prescription, and import framework, so this record reflects that general framework rather than a peptide-specific law. [1]

Compound-by-compound status

BPC-157BPC-157 is an unapproved drug/research peptide with no medicine authorization, so it cannot be lawfully marketed or sold for human use in Saudi Arabia and would only be importable through an SFDA process, if at all. [7]
Semaglutide (GLP-1, e.g. Ozempic®/Wegovy®/Glucentra)Semaglutide is legal in Saudi Arabia as an SFDA-approved, prescription-only peptide medicine for diabetes and weight management, and is available including as a licensed generic. [5]
TB-500 (thymosin beta-4)TB-500 is an unapproved research peptide with no SFDA marketing authorization, and no Saudi-specific source confirming any legal human-use pathway was located, so it should be treated as not lawfully sellable for human use. (no source found)
Human growth hormone (HGH / somatropin)HGH/somatropin is handled as a prescription-only medicine subject to SFDA control in Saudi Arabia, but a Saudi-specific primary source detailing its exact scheduling was not located in this research and this reflects general prescription-medicine inference. (no source found)

Frequently asked questions

Can I buy peptides in Saudi Arabia without a prescription?

No; in Saudi Arabia peptide medicines such as semaglutide are prescription-only SFDA-approved drugs dispensed through licensed channels, and unapproved research peptides are not legally sold at all. [6]

Can I bring peptides into Saudi Arabia for personal use when I travel?

Only with a valid prescription; Saudi Arabia introduced prescription-based personal-import rules in late 2024, and unapproved/unregistered products additionally require an SFDA authorization process, so undocumented research peptides risk being refused or seized. [2]

Are Ozempic® and semaglutide legal in Saudi Arabia?

Yes; semaglutide-class GLP-1 medicines are SFDA-approved and legally available in Saudi Arabia by prescription, including a locally launched generic and an approved oral weight-loss option. [5]

Is BPC-157 legal in Saudi Arabia?

BPC-157 is not an approved medicine anywhere and is classed as an unapproved drug, so it cannot be lawfully sold for human use in Saudi Arabia and has no straightforward legal import route. [7]

How can someone legally obtain peptides in Saudi Arabia?

Legally, a person obtains peptide medicines in Saudi Arabia only via a licensed prescriber and an SFDA-registered product dispensed through a licensed pharmacy; there is no lawful over-the-counter or 'research chemical' channel for human use. [4]

Sources

  1. General Authority for Food and Drug (SFDA), official site (retrieved 2026-09-22)
  2. Health Alert: New Prescription Regulations for Saudi Arabia, U.S. Embassy & Consulates in Saudi Arabia (retrieved 2026-09-22)
  3. Saudi Arabia: New Regulations for Personal Import and Prescription of Medications, Lexis Middle East (retrieved 2026-09-22)
  4. Import unapproved medicine into Saudi Arabia, Everyone.org (retrieved 2026-09-22)
  5. Hikma launches Glucentra as the first generic semaglutide available to patients in Saudi Arabia (retrieved 2026-09-22)
  6. SFDA approves first daily oral weight-loss drug for adults with obesity, Saudi Gazette (retrieved 2026-09-22)
  7. BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products, Operation Supplement Safety (OPSS) (retrieved 2026-09-22)

Last researched: 2026-09-22.

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in Saudi Arabia, consult a licensed attorney or the national regulator.